Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Celgene Launches Celgene Cancer Care Links TM to Support Cancer Healthcare Capacity Building in Resource-Constrained Countries

Celgene Corporation
Posted on: 05 Dec 17

Celgene Corporation (NASDAQ:CELG) today announced the launch of Celgene Cancer Care Links, a new grant program designed to support cancer healthcare capacity building in resource-constrained countries around the world. As part of this program, Celgene will collaborate with medical centers focused on enhancing patient care and building sustainable cancer care systems in resource-constrained countries. Funding will be provided to approved programs in 2018.

“Celgene’s purpose is to change the course of human health through bold pursuits in science, and promise to always put patients first,” said Mark J. Alles, Chief Executive Officer at Celgene. “As an extension of that purpose, our hope is that Celgene Cancer Care Links will support improved cancer care in some of the world’s underserved areas.”

Applications will be accepted for programs to support medical centers in resource-constrained countries around the world that provide essential cancer care services, including oncology training, cancer prevention and detection, nursing programs, general medical support, pharmacy programs, and awareness and education initiatives. Interested organizations can visit http://www.celgene.com/responsibility/global-health/celgene-cancer-care-links/ for more information about the application process.

“Celgene Cancer Care Links aims to build capacity within cancer centers to better manage prevention, early diagnosis, and treatment to improve patient lives,” said Joe Camardo, MD, Senior Vice President, Global Health and Corporate Affairs Medical Strategy at Celgene.

Celgene Cancer Care Links is the latest addition to Celgene’s global health and corporate responsibility initiatives. For additional information on Celgene’s work in global health, visit http://www.celgene.com/responsibility/global-health/. Celgene Cancer Care Links also supports Celgene’s commitment to Access Accelerated, a partnership of over 20 biopharmaceutical companies developing innovative and sustainable solutions to improve access to non-communicable disease treatment and care in low and middle-income countries.

About Celgene Cancer Care Links

Celgene Cancer Care Links is a grant program to support health care capacity initiatives that enhance patient cancer care in resource-constrained countries. Celgene Cancer Care Links is a demonstration of Celgene’s commitment to improving the lives of patients worldwide. For more information visit http://www.celgene.com/responsibility/global-health/celgene-cancer-care-links/.

About Access Accelerated

Access Accelerated is a partnership of over 20 biopharmaceutical companies working together to develop innovative and sustainable solutions to improve access to non-communicable disease treatment and care in low and middle-income countries. In addition to each company committing to do more with their individual programs, Access Accelerated also includes partnerships with the World Bank and the Union of International Cancer Control. Access Accelerated is part of the private sector’s commitment to achieving the United Nations Sustainable Development Goal target to reduce premature deaths from NCDs by 2030. More information at www.AccessAccelerated.org.

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. For more information, please visit www.celgene.com. Follow Celgene on social media: @CelgenePinterestFacebook and YouTube.

Forward-Looking Statements

This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission.

Hyperlinks are provided as a convenience and for informational purposes only. Celgene bears responsibility for the security or content of external websites or websites outside of its control.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171205005734/en/

Business Wire
www.businesswire.com

Last updated on: 05/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.